Incidence of carbapenem-resistant Pseudomonas aeruginosa in diabetes and cancer patients.
Indian J Med Microbiol
;
2008 Jul-Sep; 26(3): 238-40
Article
in English
| IMSEAR
| ID: sea-53659
ABSTRACT
Two hundred and thirty isolates of Pseudomonas aeruginosa were obtained from samples of patients having diabetes (75%), cancer (20%), and both diabetes and cancer (5%) who were admitted to a tertiary care hospital in Western India from January to December 2006. These isolates were tested for susceptibility to antipseudomonal drugs and considered to be resistant to carbapenem when the zone of inhibition around imipenem and meropenem discs was < or =13 mm. Of these 230 isolates, 26% were found to be carbapenem resistant. The rapid dissemination of carbapenem resistance is worrisome and calls for the implementation of surveillance studies as well as judicious use of antibiotics.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Pseudomonas aeruginosa
/
Pseudomonas Infections
/
Humans
/
Microbial Sensitivity Tests
/
Carbapenems
/
Beta-Lactam Resistance
/
Diabetes Complications
/
Hospitalization
/
India
/
Neoplasms
Type of study:
Incidence study
Country/Region as subject:
Asia
Language:
English
Journal:
Indian J Med Microbiol
Journal subject:
Microbiology
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS